Plain-English translation of NCT07244640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating whether a non-invasive eye scan—looking at the back of the eye (retina)—can detect Parkinson's disease in its earliest stages. This study will compare how well this new eye-scanning technology works compared to a standard brain imaging test called DAT-PET. If successful, this could offer patients a simpler, faster way to get diagnosed.
Currently, diagnosing Parkinson's disease early can be difficult and requires complex brain imaging scans. Researchers hope this new eye-scanning technology could provide an easier, non-invasive alternative that helps catch the disease sooner, when treatment may be more effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a non-invasive scan of the back of your eye (retina) performed by the research team. Depending on which group you're in (early Parkinson's, related movement disorder, essential tremor, or healthy control), you may also have standard clinical assessments and possibly a brain imaging scan (DAT-PET) for comparison. The study involves one or more visits to the hospital to complete these tests.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China